269 related articles for article (PubMed ID: 31140154)
41. Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis.
Heurling K; Leuzy A; Zimmer ER; Lubberink M; Nordberg A
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):362-373. PubMed ID: 26440450
[TBL] [Abstract][Full Text] [Related]
42. Exploratory Assessment of K-means Clustering to Classify 18F-Flutemetamol Brain PET as Positive or Negative.
Zukotynski K; Black SE; Kuo PH; Bhan A; Adamo S; Scott CJM; Lam B; Masellis M; Kumar S; Fischer CE; Tartaglia MC; Lang AE; Tang-Wai DF; Freedman M; Vasdev N; Gaudet V
Clin Nucl Med; 2021 Aug; 46(8):616-620. PubMed ID: 33883495
[TBL] [Abstract][Full Text] [Related]
43. Detection of cardiac amyloidosis with
Kircher M; Ihne S; Brumberg J; Morbach C; Knop S; Kortüm KM; Störk S; Buck AK; Reiter T; Bauer WR; Lapa C
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1407-1416. PubMed ID: 30798427
[TBL] [Abstract][Full Text] [Related]
44. Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases.
Larsen BT; Mereuta OM; Dasari S; Fayyaz AU; Theis JD; Vrana JA; Grogan M; Dogan A; Dispenzieri A; Edwards WD; Kurtin PJ; Maleszewski JJ
Histopathology; 2016 Apr; 68(5):648-56. PubMed ID: 26212778
[TBL] [Abstract][Full Text] [Related]
45. A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [
Bucci M; Savitcheva I; Farrar G; Salvadó G; Collij L; Doré V; Gispert JD; Gunn R; Hanseeuw B; Hansson O; Shekari M; Lhommel R; Molinuevo JL; Rowe C; Sur C; Whittington A; Buckley C; Nordberg A
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2183-2199. PubMed ID: 33844055
[TBL] [Abstract][Full Text] [Related]
46.
Morgenstern R; Yeh R; Castano A; Maurer MS; Bokhari S
J Nucl Cardiol; 2018 Oct; 25(5):1559-1567. PubMed ID: 28176254
[TBL] [Abstract][Full Text] [Related]
47. Radiolabeled Thioflavin-T Derivative PET Imaging for the Assessment of Cardiac Amyloidosis.
Boczar KE; Small G; Tavoosi A; Ruddy TD
Curr Cardiol Rep; 2022 Dec; 24(12):1883-1891. PubMed ID: 36378483
[TBL] [Abstract][Full Text] [Related]
48. Estimation of amyloid distribution by [
Thal DR; Beach TG; Zanette M; Lilja J; Heurling K; Chakrabarty A; Ismail A; Farrar G; Buckley C; Smith APL
Acta Neuropathol; 2018 Oct; 136(4):557-567. PubMed ID: 30123935
[TBL] [Abstract][Full Text] [Related]
49. 18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review.
Mekinian A; Jaccard A; Soussan M; Launay D; Berthier S; Federici L; Lefèvre G; Valeyre D; Dhote R; Fain O;
Amyloid; 2012 Jun; 19(2):94-8. PubMed ID: 22587492
[TBL] [Abstract][Full Text] [Related]
50. [Consideration of the Residual Radioactivity of Amyloid Imaging Agent
Sato K; Kimura S; Okuyama Y
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2020; 76(12):1276-1280. PubMed ID: 33342946
[TBL] [Abstract][Full Text] [Related]
51. Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients.
Leinonen V; Rinne JO; Virtanen KA; Eskola O; Rummukainen J; Huttunen J; von Und Zu Fraunberg M; Nerg O; Koivisto AM; Rinne J; Jääskeläinen JE; Buckley C; Smith A; Jones PA; Sherwin P; Farrar G; McLain R; Kailajärvi M; Heurling K; Grachev ID
Eur J Neurol; 2013 Jul; 20(7):1043-52. PubMed ID: 23398333
[TBL] [Abstract][Full Text] [Related]
52. 18F-fluoride PET/MR in cardiac amyloid: A comparison study with aortic stenosis and age- and sex-matched controls.
Andrews JPM; Trivieri MG; Everett R; Spath N; MacNaught G; Moss AJ; Doris MK; Pawade T; van Beek EJR; Lucatelli C; Newby DE; Robson P; Fayad ZA; Dweck MR
J Nucl Cardiol; 2022 Apr; 29(2):741-749. PubMed ID: 33000405
[TBL] [Abstract][Full Text] [Related]
53. Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment.
Janelidze S; Pannee J; Mikulskis A; Chiao P; Zetterberg H; Blennow K; Hansson O
JAMA Neurol; 2017 Dec; 74(12):1492-1501. PubMed ID: 29114726
[TBL] [Abstract][Full Text] [Related]
54. PET-CT evaluation of amyloid systemic involvement with [
Genovesi D; Vergaro G; Emdin M; Giorgetti A; Marzullo P
J Nucl Cardiol; 2017 Dec; 24(6):2025-2029. PubMed ID: 28326465
[TBL] [Abstract][Full Text] [Related]
55. β-Amyloid may accumulate in the human brain after focal bacterial infection: An
Rogne AG; Müller EG; Udnaes E; Sigurdardottir S; Raudeberg R; Connelly JP; Revheim ME; Hassel B; Dahlberg D
Eur J Neurol; 2021 Mar; 28(3):877-883. PubMed ID: 33131195
[TBL] [Abstract][Full Text] [Related]
56. Flutemetamol (18F): a β-amyloid positron emission tomography tracer for Alzheimer's and dementia diagnosis.
de Lartigue J
Drugs Today (Barc); 2014 Mar; 50(3):219-29. PubMed ID: 24696867
[TBL] [Abstract][Full Text] [Related]
57. Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer's disease, subjects with amnestic mild cognitive impairment and healthy volunteers.
Miki T; Shimada H; Kim JS; Yamamoto Y; Sugino M; Kowa H; Heurling K; Zanette M; Sherwin PF; Senda M
Ann Nucl Med; 2017 Apr; 31(3):260-272. PubMed ID: 28181118
[TBL] [Abstract][Full Text] [Related]
58. Significance of
Minamimoto R; Awaya T; Iwama K; Hotta M; Nakajima K; Hirai R; Okazaki O; Hiroi Y
J Nucl Cardiol; 2020 Feb; 27(1):202-209. PubMed ID: 29589208
[TBL] [Abstract][Full Text] [Related]
59. Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study.
Wechalekar A; Antoni G; Al Azzam W; Bergström M; Biswas S; Chen C; Cheriyan J; Cleveland M; Cookson L; Galette P; Janiczek RL; Kwong RY; Lukas MA; Millns H; Richards D; Schneider I; Solomon SD; Sörensen J; Storey J; Thompson D; van Dongen G; Vugts DJ; Wall A; Wikström G; Falk RH
BMC Cardiovasc Disord; 2022 Feb; 22(1):49. PubMed ID: 35152886
[TBL] [Abstract][Full Text] [Related]
60. Cerebellar and Cerebral Amyloid Visualized by [
Uneus EI; Wilhelmsson C; Bäckström D; Anan I; Wixner J; Pilebro B; Riklund K; Ögren M; Ögreen M; Axelsson J; Suhr OB; Sundström T
Front Neurol; 2022; 13():816636. PubMed ID: 35317351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
